Dipping in 2020
30/12/19 -"We have re-worked our financial model after some initial adjustments. Our general view on the company remains broadly unchanged, but the incorporation of the AR's full set of figures and a stronger ..."
Pages
72
Language
English
Published on
30/12/19
You may also be interested by these reports :
05/08/26
Fresenius delivered a strong Q2, with adjusted EBIT and core EPS coming in comfortably ahead of expectations and revenue broadly in line. The beat ...
03/08/26
Our TP has been cut slightly, reflecting an update to the model (net debt, and updated market parameters), with no change to the operational ...
03/08/26
Smart glasses development continues to erode margins. We will take a more conservative view of the company and revise our long-term margin ...
02/08/26
DiaSorin’s Q2 profitability surpassed expectations. Despite weak respiratory sales and challenges in China, revenue grew by mid-single digits. All ...